Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Circulating microRNA screening of high-risk individuals enrolled in COSMOS lung cancer screening trial.


ABSTRACT: Lung cancer is the leading cause of cancer death worldwide. Low-dose computed tomography screening (LDCT) was recently shown to anticipate the time of diagnosis, thus reducing lung cancer mortality. We identifed a serum microRNA signature (the miR-Test) that could identify the optimal target population for LDCT screening. Here, we performed a large-scale validation study of the miR-Test in high-risk individuals enrolled in the Continuous Observation of Smoking Subjects (COSMOS) lung cancer screening program. RT-qPCR of circulating microRNA purified from serum samples. Trizol-LS and miRNEASY Mini kit (Qiagen) were used for miRNA purification. Custom TaqMan® Low Density Array microRNA Custom Panel (Life Technologies) was used to screen serum circulating microRNA.

ORGANISM(S): Homo sapiens

SUBMITTER: Fabrizio Bianchi 

PROVIDER: E-GEOD-76462 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2012-05-15 | E-GEOD-37972 | biostudies-arrayexpress
2013-10-22 | E-GEOD-51503 | biostudies-arrayexpress
2014-09-30 | E-GEOD-37766 | biostudies-arrayexpress
2014-08-01 | E-GEOD-44121 | biostudies-arrayexpress
2016-03-22 | E-GEOD-79181 | biostudies-arrayexpress
2014-06-21 | E-GEOD-44899 | biostudies-arrayexpress
2013-10-22 | E-GEOD-51508 | biostudies-arrayexpress
2010-07-06 | E-GEOD-21220 | biostudies-arrayexpress
2013-08-08 | E-GEOD-24149 | biostudies-arrayexpress
2015-07-14 | E-GEOD-70856 | biostudies-arrayexpress